News tagged with androgen receptors

Scientists solve key piece of prostate cancer puzzle

Cancer Research UK scientists have revealed a completely new route by which male androgen hormones fuel the growth of prostate cancer, raising the prospect that existing drugs could be used to treat the disease.

Cancer Aug 14, 2012 | 5 / 5 (2) | 0 |

New therapeutic target for prostate cancer identified

A small, naturally occurring nucleic acid sequence, called a microRNA, known to regulate a number of different cancers, appears to alter the activity of the androgen receptor, which plays a critical role in ...

Cancer Jul 17, 2012 | not rated yet | 0

Experimental drug improves muscle strength among male cancer patients

An experimental medication safely increases muscle strength and physical functioning among cancer patients with low testosterone levels, a new drug study finds. The results will be presented at The Endocrine Society's 94th ...

Medical research Jun 25, 2012 | not rated yet | 0

Capability of curry component to treat disease merits US patent

A U.S patent issued today to the University of Rochester and two other entities for the use of compounds related to a popular spice in the fight against cancer, acne, baldness, and other medical conditions.

Medical research Jun 12, 2012 | 3.7 / 5 (3) | 2

New target, new drug in breast cancer

Many breast cancers depend on hormones including estrogen or progesterone for their survival and proliferation. Eight years of lab work at the University of Colorado Cancer Center and elsewhere suggest that the androgen (AR) ...

Cancer Jun 04, 2012 | 5 / 5 (1) | 0

Low testosterone levels could raise diabetes risk for men

Low levels of testosterone in men could increase their risk of developing diabetes, a study suggests.

Medical research May 04, 2012 | 5 / 5 (1) | 0 |

Early clinical data show galeterone safe, effective against prostate cancer

Patients with castration-resistant prostate cancer had limited side effects and in many cases a drop in prostate-specific antigen expression with galeterone (TOK-001), a small-molecule oral drug, according to phase I data ...

Cancer Apr 01, 2012 | 5 / 5 (1) | 0

Study role testosterone may play in triple negative breast cancer

Could blocking a testosterone receptor lead to a new way to treat an aggressive form of breast cancer? That's a question researchers at Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) are exploring. ...

Cancer Mar 23, 2012 | 5 / 5 (1) | 0 |

Curry spice component may help slow prostate tumor growth

Curcumin, an active component of the Indian curry spice turmeric, may help slow down tumor growth in castration-resistant prostate cancer patients on androgen deprivation therapy (ADT), a study from researchers ...

Cancer Feb 10, 2012 | 4.5 / 5 (10) | 0 |

Study identifies new prostate cancer drug target

Research led by Wanguo Liu, PhD, Associate Professor of Genetics at LSU Health Sciences Center New Orleans, has identified a new protein critical to the development and growth of prostate cancer. The findings are published ...

Cancer Feb 06, 2012 | 5 / 5 (2) | 0 |

New drug extends survival in patients with drug-resistant prostate cancer

A new drug, MDV3100, is improving the survival rate in men with advanced prostate cancer, results of a large, phase III clinical trial show. The drug is designed to block a type of cellular receptor that drives progression ...

Cancer Feb 01, 2012 | 5 / 5 (1) | 0 |

Study finds new points of attack on breast cancers not fueled by estrogen

Although it sounds like a case of gender confusion on a molecular scale, the male hormone androgen spurs the growth of some breast tumors in women. In a new study, scientists at Dana-Farber Cancer Institute provide the first ...

Cancer Jul 11, 2011 | not rated yet | 0 |

Finger ratio points to penile length

The ratio between the second and fourth digits is linked to stretched penile length according to a study published online this week in Asian Journal of Andrology. This finding suggests that digit ratio can predict adult ...

Other Jul 05, 2011 | 3.8 / 5 (4) | 5

Prostate cancer gets around hormone therapy by activating a survival cell signaling pathway

Cancer is crafty. When one avenue driving its growth is blocked by drugs targeting that path, the malignancy often creates a detour, finding an alternative route to get around the roadblock.

Cancer Jun 14, 2011 | not rated yet | 0 |

Targeted cancer therapy kills prostate tumor cells

A new targeted therapy for prostate cancer halts tumor growth in animals with advanced prostate cancer that is resistant to hormone therapy, a new study finds. The results will be presented Saturday at The Endocrine Society's ...

Cancer Jun 06, 2011 | not rated yet | 0 |

Pages: 1 2